Showing results (371-380 of 412) with videos related to

Sort By:
Pageof 42
The American Journal of Pathology|October 15, 2022
Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial IntelligenceHong Zhang, Muhammad A Qureshi, Mohsin Wahid, et al.
Leukemia Research|August 19, 2003
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phaseFrancis J Giles, Eric J Feldman, Gail J Roboz, et al.
Blood|August 28, 2009
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapseFrancis Giles, Norbert Vey, Daniel DeAngelo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responsesJorge E Cortes, Hagop M Kantarjian, Stuart L Goldberg, et al.
Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Biotechnology Research International|March 24, 2016
Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic MalignanciesMahmoud Aljurf, Hala Abalkhail, Amal Alseraihy, et al.
Mayo Clinic Proceedings|August 6, 2020
Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance TherapyHasan Ahmad Hasan Albitar, Yahya Almodallal, Alice Gallo De Moraes, et al.
Gynecologic Oncology|November 14, 2012
Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53Xiangbing Meng, Laura L Laidler, Elizabeth A Kosmacek, et al.
Cancer|March 26, 2003
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemiaApostolia M Tsimberidou, Hagop M Kantarjian, Jorge Cortes, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Pageof 42